David Shaw’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

David Shaw’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$526K	–	5512
2021 Q3	$526K	Hold	10,000	–	–	﹤0.01%	4058
2021 Q2	$689K	Hold	10,000	–	–	﹤0.01%	3839
2021 Q1	$771K	Buy	+10,000	New	+$921K	﹤0.01%	3287
2020 Q4	–	Sell	-10,000	Closed	-$1.42M	–	4003
2020 Q3	$1.42M	Hold	10,000	–	–	﹤0.01%	2626
2020 Q2	$1.97M	Hold	10,000	–	–	﹤0.01%	2416
2020 Q1	$1.96M	Hold	10,000	–	–	﹤0.01%	2186
2019 Q4	$2.07M	Buy	+10,000	New	+$1.85M	﹤0.01%	2435

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

David Shaw's LKFT Position: Q2 2026 in Review

David Shaw reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 8.3% in Q2 2026, selling an estimated $507K and leaving 197,844 shares worth $5.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

David Shaw first reported a position in LKFT in Q3 2018 and has held it in 27 quarters since. The position peaked at $8.99M in Q4 2025. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

David Shaw held 197,844 shares of Lakefront Biotherapeutics American Depositary Shares worth $5.93M as of Q2 2026.
David Shaw sold 17,874 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $507K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2263 holding.
David Shaw first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 27 quarters since.
David Shaw's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.99M in Q4 2025.
77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.